Background alzheimers Shape Background alzheimers Shape Background alzheimers Shape
Grants > Understanding Brain Networks Causing Associative Memory Impairments in AD Updated On: Jan. 20, 2025
Alzheimer's Disease Research Grant

Understanding Brain Networks Causing Associative Memory Impairments in AD

Cells & Circuits
a headshot of Dr. Nakagawa

Principal Investigator

Tatsuki Nakagawa, PhD

University of California, Irvine

Irvine, CA, USA

About the Research Project

Program

Alzheimer's Disease Research

Award Type

Postdoctoral Fellowship

Award Amount

$200,000

Active Dates

July 01, 2022 - June 30, 2025

Grant ID

A2022018F

Goals

We will identify target neural circuits and cells that will slow or mitigate the progression of associative memory impairments in AD.

Summary

Alzheimer’s disease (AD) affects 6 million people in the US, but no cure exists. Although molecular and cellular mechanisms of AD become clearer, it is still unclear what type of neuronal brain activity is lost in AD. If we understand this, we may be able to develop a therapy to prevent memory loss in AD patients. In this project, we will identify the underlying causes of brain cell dysfunction, and test if artificial reactivation of brain cell activity restores associative memory in AD mice. These studies are expected to lead to a new method for restoring memory in AD patients.

Unique and Innovative

We are one of the only few labs studying circuit mechanisms underlying associative memory in the lateral entorhinal cortex, and presumably the first lab that focuses on the associative memory impairment in AD. Our lab has all experimental setups for the proposed in vivo electrophysiological recording and an associative learning behavioral paradigm. The proposed study represents high innovation because these systems neuroscience-oriented methods have not been applied in the AD research field.

Foreseeable Benefits

My research will help us identify target neural circuits to prevent progression of AD and to slow or mitigate the progression of associative memory impairments in AD patients. Our results may also lead to the future development of effective circuit-based therapeutics applicable to preserve or improve memory function in AD patients, including brain reactivation using deep-brain stimulation.